SavedAdd your journal

Journals / Damar Cerrahi Dergisi / 2017 / Cilt: 26 - Sayı: 2

Removal of detached pharmacomechanical rotational thrombectomy device tip inside deep vein using Fogarty® catheter

Farmakomekanik rotasyonel trombektomi cihazının derin ven içerisinde kopan ucunun Fogarty® kateteri kullanılarak çıkartılması

Hamit Serdar BAŞBUĞ
Kevser TURAL
Macit BİTARGİL
Kanat ÖZIŞIK
Hakan GÖÇER
Yalçın GÜNERHAN
Pages
43–45
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, we present a 26-year-old male patient with deep vein thrombosis in whom the tip of the catheter was split in the femoral vein during percutaneous pharmacomechanical thrombectomy and this complication was successfully treated with a percutaneous Fogarty® catheter with the aid of opaque agent under scopy

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In case of deep vein thrombosis, prevention of thromboembolic complications and pulmonary embolism is possible via medical treatment.
📊
Key Findings & Data:However, since current anticoagulation treatment is not a thrombolytic treatment and is unable to lyse the clot, thrombus obstruction and associated venous hypertension may lead to valve destruction in the late term.
💡
Conclusion & Impact:In this article, we present a 26-year-old male patient with deep vein thrombosis in whom the tip of the catheter was split in the femoral vein during percutaneous pharmacomechanical thrombectomy and this complication was successfully treated with a percutaneous Fogarty® catheter with the aid of opaque agent under scopy
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In case of deep vein thrombosis, prevention of thromboembolic complications and pulmonary embolism is possible via medical treatment. However, since current anticoagulation treatment is not a thrombolytic treatment and is unable to lyse the clot, thrombus obstruction and associated venous hypertension may lead to valve destruction in the late term. As a result, venous insufficiency and venous ulcers may develop. Nonetheless, these late manifestations, which are known as post-thrombotic syndrome, due to deep vein thrombosis are likely to be avoided. Surgical thrombectomy, catheter-directed fibrinolytic therapy, and percutaneous pharmacomechanical thrombectomy are among the current methods used. In this article, we present a 26-year-old male patient with deep vein thrombosis in whom the tip of the catheter was split in the femoral vein during percutaneous pharmacomechanical thrombectomy and this complication was successfully treated with a percutaneous Fogarty® catheter with the aid of opaque agent under scopy

Özet

Derin ven trombozu söz konusu olduğunda, tıbbi tedaviyle tromboembolik komplikasyonların ve pulmoner tromboembolinin önüne geçmek mümkündür. Ancak mevcut antikoagülasyon tedavisi trombolitik bir tedavi olmadığından ve pıhtıyı eritemediğinden, trombüs obstrüksiyonu ve buna bağlı gelişen venöz hipertansiyon geç dönemde kapak harabiyetine yol açabilmektedir. Bunun sonucunda da, venöz yetmezlik ve venöz ülserler oluşabilmektedir. Yine de, derin ven trombozu sonucu postrombotik sendrom olarak anılan bu geç dönem bulgularının önüne geçebilmek mümkündür. Cerrahi trombektomi, kateter yönlendirmeli fibrinolitik tedavi ve perkütan farmakomekanik trombektomi kullanılan mevcut yöntemlerden bazılarıdır. Bu yazıda, derin ven trombozu nedeni ile 26 yaşında bir erkek hastada perkütan farmakomekanik trombektomi tedavisi sırasında kateter ucunun kırılarak femoral vende kalması sonucu oluşan komplikasyonun perkütan olarak skopi altında opak madde destekli Fogarty® kateteri ile başarılı tedavisi sunuldu

🔖

Cite This Article

BAŞBUĞ, H. S., TURAL, K., BİTARGİL, M., ÖZIŞIK, K., GÖÇER, H., GÜNERHAN, Y. (2022). Removal of detached pharmacomechanical rotational thrombectomy device tip inside deep vein using Fogarty® catheter. Damar Cerrahi Dergisi, Cilt: 26 - Sayı: 2, 43–45. https://ajindex.com/articles/486640

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991;151:933-8
  2. Kahn SR, Shrier I, Julian JA, Ducruet T, Arsenault L, Miron MJ, et al. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med 2008;149:698-707
  3. Bush RL, Lin PH, Bates JT, Mureebe L, Zhou W, Lumsden AB. Pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis: safety and feasibility study. J Vasc Surg 2004;40:965-70
  4. Karthikesalingam A, Young EL, Hinchliffe RJ, Loftus IM, Thompson MM, Holt PJ. A systematic review of percutaneous mechanical thrombectomy in the treatment of deep venous thrombosis. Eur J Vasc Endovasc Surg 2011;41:554-65
  5. Meissner MH, Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG, Gillespie DL, et al. Early thrombus removal strategies for acute deep venous thrombosis: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2012;55:1449-62
  6. Cardiovascular Disease Educational and Research Trust; Cyprus Cardiovascular Disease Educational and Research Trust; European Venous Forum; International Surgical Thrombosis Forum; International Union of Angiology; Union Internationale de Phlébologie. Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence). Int Angiol 2006;25:101-61
  7. Frisoli JK, Sze D. Mechanical thrombectomy for the treatment of lower extremity deep vein thrombosis. Tech Vasc Interv Radiol 2003;6:49-52.